Conventional vs biologic treatment for pediatric inflammatory bowel disease
Part of Digestive system clinical trials.
This study compares standard treatments (like steroids or immunosuppressants) with biologic therapies (which target specific immune pathways) for children and teens with inflammatory bowel disease (IBD), which includes Crohn's disease and ulcerative colitis. The goal is to see which approach works better for controlling symptoms and maintaining remission.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You or your child must have a confirmed diagnosis of Crohn's disease, ulcerative colitis, or IBD-unclassified.
- The diagnosis must have been made before age 18.
- You must have been treated with either conventional therapy (like steroids or immunosuppressants) or biologic therapy (like infliximab or adalimumab) for a period long enough to evaluate its effect.
- Full medical records must be available for review.
- If participating in the prospective part, written informed consent is required.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is for children and teens with inflammatory bowel disease (Crohn's, colitis, or indeterminate) whose previous anti-TNF medicine stopped working. It compares several newer treatments to see which works best.
This trial studies a combination of immune-suppressing treatments for children with Crohn’s disease that is not well controlled. It may help reduce inflammation and improve symptoms if you meet the study’s disease-activity and safety requirements.
This study looks at blood and/or tissue “molecular” (cell-level) reasons why treatments don’t fully work in adults with Crohn’s disease or ulcerative colitis. If you are starting a biologic or small-molecule medicine and still have moderate to severe symptoms, you may be able to contribute to research that helps improve future care.
This study compares different blood tests that measure the amount of biologic medication in your body. The goal is to see if simpler tests give the same results as standard ones, which could make monitoring easier for patients with inflammatory bowel disease.
This study looks at health records of children in Korea who have inflammatory bowel disease (Crohn's disease or ulcerative colitis) to understand their medical care, treatments, and healthcare use. Researchers are not testing a new drug—they're analyzing existing medical information to learn more about how these diseases are managed in children.
This study follows children with inflammatory bowel disease (IBD) to learn more about the disease and improve care. It may help doctors understand how to treat Crohn's disease, ulcerative colitis, or IBD that doesn't fit either diagnosis.
Hear when a new Ulcerative Colitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.